Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
The FDA has approved nivolumab for treating patients with recurrent or metastatic squamous cell carcinoma of the head...
Since 1996, the Associate Member Council (AMC) has served as the leadership body for associate members of the American...
Cancer Today empowers readers to be active and involved in their treatment and survivor experiences.
Later this week, more than 200 researchers will convene in Montreal for a four-day conference on DNA Repair: Tumor...
The AACR is a founder and organizing partner of the Rally for Medical Research, which took place for the...
This month is Breast Cancer Awareness Month, a type of cancer against which we have made much progress. However,...
Last week, the U.S. Food and Drug Administration (FDA) added a new therapeutic to the armamentarium for oncologists treating...
Earlier this week, the U.S. Food and Drug Association (FDA) announced it had approved the immunotherapeutic atezolizumab (Tecentriq) for...
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett...
Liver cancer rates have been on the rise in the United States and have tripled in the last four...